These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16952315)

  • 1. A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: implications for radiation dose escalation in carcinoma of the pancreas.
    Singh AK; Tierney RM; Low DA; Parikh PJ; Myerson RJ; Deasy JO; Wu CS; Pereira GC; Wahab SH; Mutic S; Grigsby PW; Hope AJ
    Radiat Oncol; 2006 Sep; 1():33. PubMed ID: 16952315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.
    Thompson RF; Mayekar SU; Zhai H; Both S; Apisarnthanarax S; Metz JM; Plastaras JP; Ben-Josef E
    Med Phys; 2014 Aug; 41(8):081711. PubMed ID: 25086521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer.
    Nuyttens JJ; Robertson JM; Yan D; Martinez A
    Cancer Radiother; 2004 Oct; 8(5):297-304. PubMed ID: 15561595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-Volume Histogram Analysis of Stereotactic Body Radiotherapy Treatment of Pancreatic Cancer: A Focus on Duodenal Dose Constraints.
    Goldsmith C; Price P; Cross T; Loughlin S; Cowley I; Plowman N
    Semin Radiat Oncol; 2016 Apr; 26(2):149-56. PubMed ID: 27000512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of treatment technique on dose-volume histogram and normal tissue complication probability for small bowel and bladder. A prospective study using a 3-D planning system and a radiobiological model in patients receiving postoperative pelvic irradiation.
    Kölbl O; Richter S; Flentje M
    Strahlenther Onkol; 2000 Mar; 176(3):105-11. PubMed ID: 10742830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer.
    Taniguchi CM; Murphy JD; Eclov N; Atwood TF; Kielar KN; Christman-Skieller C; Mok E; Xing L; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1090-5. PubMed ID: 23273994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small bowel displacement system-assisted intensity-modulated radiotherapy for cervical cancer.
    Huh SJ; Kang MK; Han Y
    Gynecol Oncol; 2004 May; 93(2):400-6. PubMed ID: 15099953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consolidating duodenal and small bowel toxicity data via isoeffective dose calculations based on compiled clinical data.
    Prior P; Tai A; Erickson B; Allen Li X
    Pract Radiat Oncol; 2014; 4(2):e125-e131. PubMed ID: 24890358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer.
    Park W; Huh SJ; Lee JE; Han Y; Shin E; Ahn YC; Lim DH
    Gynecol Oncol; 2005 Dec; 99(3):645-51. PubMed ID: 16154184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
    Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum].
    Goupy F; Chajon E; Castelli J; Le Prisé É; Duvergé L; Jaksic N; Vogin G; Monpetit É; Klein V; de Bosschère L; Maingon P
    Cancer Radiother; 2017 Oct; 21(6-7):613-618. PubMed ID: 28886980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting Reduces Intestinal Radiotoxicity, Enabling Dose-Escalated Radiation Therapy for Pancreatic Cancer.
    de la Cruz Bonilla M; Stemler KM; Jeter-Jones S; Fujimoto TN; Molkentine J; Asencio Torres GM; Zhang X; Broaddus RR; Taniguchi CM; Piwnica-Worms H
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):537-547. PubMed ID: 31271824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
    Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
    Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer.
    Gunnlaugsson A; Kjellén E; Nilsson P; Bendahl PO; Willner J; Johnsson A
    Acta Oncol; 2007; 46(7):937-44. PubMed ID: 17851844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoradiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study.
    Henry AM; Ryder WD; Moore C; Sherlock DJ; Geh JI; Dunn P; Price P
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):541-7. PubMed ID: 18562186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.
    Murphy JD; Christman-Skieller C; Kim J; Dieterich S; Chang DT; Koong AC
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1420-6. PubMed ID: 20399033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison of doses to organs at risk using 3-D conformal radiotherapy versus intensity modulated radiotherapy in postoperative radiotherapy of periampullary cancers: implications for radiation dose escalation.
    Bahl A; Kapoor R; Tomar P; Singh OA; Gupta R; Sharma SC
    JOP; 2013 Jan; 14(1):39-43. PubMed ID: 23306333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.